Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 280

1.

The Validity of Claims-Based Algorithms to Identify Serious Hypersensitivity Reactions and Osteonecrosis of the Jaw.

Wright NC, Curtis JR, Arora T, Smith WK, Kilgore ML, Saag KG, Safford MM, Delzell ES.

PLoS One. 2015 Jul 10;10(7):e0131601. doi: 10.1371/journal.pone.0131601. eCollection 2015.

2.

An Internet-based Controlled Trial Aimed to Improve Osteoporosis Prevention among Chronic Glucocorticoid Users.

Warriner AH, Outman RC, Allison JJ, Curtis JR, Markward NJ, Redden DT, Safford MM, Stanek EJ, Steinkellner AR, Saag KG.

J Rheumatol. 2015 Jul 1. pii: jrheum.141238. [Epub ahead of print]

PMID:
26136484
3.

The Comparative Effectiveness of Biologics among Older Adults and Disabled Rheumatoid Arthritis Patients in the Medicare Population.

Yun H, Xie F, Delzell E, Chen L, Yang S, Saag KG, Joseph G, Harrison D, Curtis JR.

Br J Clin Pharmacol. 2015 Jun 30. doi: 10.1111/bcp.12709. [Epub ahead of print]

PMID:
26130274
4.

Balancing the benefits and risks of low-dose glucocorticoid in rheumatoid arthritis.

Santiago T, Jacobs JW, Saag KG, Buttgereit F, Pereira da Silva JA.

Acta Reumatol Port. 2015 Jan-Mar;40(1):10-22.

5.

Improving bone mineral density reporting to patients with an illustration of personal fracture risk.

Edmonds SW, Cram P, Lu X, Roblin DW, Wright NC, Saag KG, Solimeo SL; PAADRN Investigators.

BMC Med Inform Decis Mak. 2014 Nov 25;14:101. doi: 10.1186/s12911-014-0101-y.

6.

Risk of hospitalized infection among rheumatoid arthritis patients concurrently treated with a biologic agent and denosumab.

Curtis JR, Xie F, Yun H, Saag KG, Chen L, Delzell E.

Arthritis Rheumatol. 2015 Jun;67(6):1456-64. doi: 10.1002/art.39075.

PMID:
25708920
7.

Modifiable factors associated with allopurinol adherence and outcomes among patients with gout in an integrated healthcare system.

Rashid N, Coburn BW, Wu YL, Cheetham TC, Curtis JR, Saag KG, Mikuls TR.

J Rheumatol. 2015 Mar;42(3):504-12. doi: 10.3899/jrheum.140588. Epub 2014 Dec 15.

PMID:
25512479
8.

Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients.

Zhang J, Xie F, Delzell E, Yun H, Lewis JD, Haynes K, Chen L, Beukelman T, Saag KG, Curtis JR.

Arthritis Care Res (Hoboken). 2015 May;67(5):624-32. doi: 10.1002/acr.22510.

PMID:
25370912
9.

Screening Questions for Nonsteroidal Anti-inflammatory Drug Risk Knowledge.

van den Bogert CA, Miller MJ, Cobaugh DJ, Chen L, Allison JJ, Saag KG.

J Patient Saf. 2014 Oct 1. [Epub ahead of print]

PMID:
25275383
10.

Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapy.

Yun H, Xie F, Delzell E, Chen L, Levitan EB, Lewis JD, Saag KG, Beukelman T, Winthrop K, Baddley JW, Curtis JR.

Arthritis Care Res (Hoboken). 2015 May;67(5):731-6. doi: 10.1002/acr.22470.

PMID:
25201241
11.

Fracture mortality: associations with epidemiology and osteoporosis treatment.

Sattui SE, Saag KG.

Nat Rev Endocrinol. 2014 Oct;10(10):592-602. doi: 10.1038/nrendo.2014.125. Epub 2014 Aug 5. Review.

PMID:
25091729
12.

Fractures and mortality in relation to different osteoporosis treatments.

Yun H, Delzell E, Saag KG, Kilgore ML, Morrisey MA, Muntner P, Matthews R, Guo L, Wright N, Smith W, Colón-Emeric C, O'Connor CM, Lyles KW, Curtis JR.

Clin Exp Rheumatol. 2015 May-Jun;33(3):302-9. Epub 2014 Jul 28.

PMID:
25068266
13.

Effect of self-referral on bone mineral density testing and osteoporosis treatment.

Warriner AH, Outman RC, Feldstein AC, Roblin DW, Allison JJ, Curtis JR, Redden DT, Rix MM, Robinson BE, Rosales AG, Safford MM, Saag KG.

Med Care. 2014 Aug;52(8):743-50. doi: 10.1097/MLR.0000000000000170.

PMID:
24984211
14.

Use of oral and subcutaneous methotrexate in rheumatoid arthritis patients in the United States.

Curtis JR, Zhang J, Xie F, Beukelman T, Chen L, Fernandes J, Ginsberg S, Spettell C, Yun H, Saag KG, Schiff M.

Arthritis Care Res (Hoboken). 2014 Nov;66(11):1604-11. doi: 10.1002/acr.22383.

PMID:
24942466
15.

Developing a bone mineral density test result letter to send to patients: a mixed-methods study.

Edmonds SW, Solimeo SL, Lu X, Roblin DW, Saag KG, Cram P.

Patient Prefer Adherence. 2014 Jun 5;8:827-41. doi: 10.2147/PPA.S60106. eCollection 2014.

16.

A group-randomized trial of shared decision making for non-steroidal anti-inflammatory drug risk awareness: primary results and lessons learned.

Miller MJ, Allison JJ, Cobaugh DJ, Ray MN, Saag KG.

J Eval Clin Pract. 2014 Oct;20(5):638-48. doi: 10.1111/jep.12193. Epub 2014 Jun 11.

PMID:
24916786
17.

Relationship between diclofenac dose and risk of gastrointestinal and cardiovascular events: meta-regression based on two systematic literature reviews.

Odom DM, Mladsi DM, Saag KG, Sherif BN, Miles L, Ronquest N, Wang J.

Clin Ther. 2014 Jun 1;36(6):906-17. doi: 10.1016/j.clinthera.2014.04.012. Epub 2014 May 23.

18.

Bone safety of low-dose glucocorticoids in rheumatic diseases.

Saag KG.

Ann N Y Acad Sci. 2014 May;1318:55-64. doi: 10.1111/nyas.12446. Epub 2014 May 9.

PMID:
24815076
19.

The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine.

Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, Dawson-Hughes B.

J Bone Miner Res. 2014 Nov;29(11):2520-6. doi: 10.1002/jbmr.2269.

PMID:
24771492
20.

Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy.

Yun H, Xie F, Delzell E, Chen L, Levitan EB, Lewis JD, Saag KG, Beukelman T, Winthrop K, Baddley JW, Curtis JR.

Ann Rheum Dis. 2015 Jun;74(6):1065-71. doi: 10.1136/annrheumdis-2013-204011. Epub 2014 Mar 7.

PMID:
24608404
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk